CRISPR enabled multiplexed genome engineering

US10731180B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10731180-B2
Application numberUS-202016773712-A
CountryUS
Kind codeB2
Filing dateJan 27, 2020
Priority dateFeb 11, 2014
Publication dateAug 4, 2020
Grant dateAug 4, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are methods and vectors for rational, multiplexed manipulation of chromosomes within open reading frames (e.g., in protein libraries) or any segment of a chromosome in a cell or population of cells, in which various CRISPR systems are used.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of generating a cell having a genome edit in one or more target regions, said method comprising: (a) introducing into said cell an editing cassette, wherein said editing cassette comprises a sequence having the following covalently-linked components: (i) a nucleic add encoding a gRNA sequence targeting a target region, (ii) a region homologous to said target region comprising a change in sequence relative to said target region, and (iii) a mutation preventing nuclease binding at a protospacer adjacent motif (PAM); and (b) creating the genome edits by introducing into said cell a nuclease compatible with said gRNA sequence; thereby generating the cell having the genome edit. 2. The method of claim 1 , wherein said gRNA sequence is a chimeric guide RNA. 3. The method of claim 1 , wherein said gRNA sequence comprises a crRNA and a tracrRNA. 4. The method of claim 1 , wherein said cell is a prokaryotic cell. 5. The method of claim 1 , wherein said cell is an eukaryotic cell. 6. The method of claim 1 , wherein the change in sequence relative to the target region is within a coding region of the target region. 7. The method of claim 1 , where in the change in sequence relative to the target region is within a non-coding region of the target region. 8. The method of claim 1 , wherein said cell comprises a change in sequence in at least two different target regions. 9. The method of claim 1 , wherein said cell comprises different changes within a same target region. 10. A method of generating a library of cells with genome edits, said method comprising: (a) obtaining a library of editing cassettes, wherein said library of editing cassette comprises one or more editing cassettes comprising the following, covalently-linked components: (i) a nucleic acid encoding a gRNA sequence targeting a target region, (ii) a change in a sequence relative to said target region, and (iii) a mutation preventing nuclease binding at a protospacer adjacent motif (PAM); (b) introducing said one or more editing cassettes from said library of editing cassettes into a population of cells, (c) introducing a nuclease compatible with said gRNA sequence into said population of cells to produce a population of edited cells, and (d) growing said population of edited cells, thereby generating said library of cells with genome edits. 11. The method of claim 10 , wherein the target region is in a non-coding region. 12. The method of claim 10 , wherein the target region is in a coding region. 13. The method of claim 10 , wherein the library comprises cells with a change in sequence in at least two different target regions. 14. The method of claim 10 , wherein the library comprises cells with at least two different changes within the same target region. 15. The method of claim 10 , wherein said region homologous to said target region is 100 to 120 nucleotides in length. 16. The method of claim 10 , wherein said PAM mutation is 17 to 59 base pairs from said change in sequence relative to said target region. 17. The method of claim 10 , wherein said mutation preventing nuclease binding at a protospaced adjacent motif (PAM) is within a coding region of the target region, and the mutation is a synonymous mutation. 18. The method of claim 10 , wherein said gRNA sequence comprises a crRNA and a tracrRNA.

Assignees

Inventors

Classifications

  • Libraries, arrays · CPC title

  • Stem-loop; Hairpin · CPC title

  • involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • C12N15/102Primary

    Mutagenizing nucleic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10731180B2 cover?
Described herein are methods and vectors for rational, multiplexed manipulation of chromosomes within open reading frames (e.g., in protein libraries) or any segment of a chromosome in a cell or population of cells, in which various CRISPR systems are used.
Who is the assignee on this patent?
Univ Colorado Regents
What technology area does this patent fall under?
Primary CPC classification C12N15/102. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).